olympic ghk cu GHK-Cu | Research Peptide GHK-Cu Scalp Solution | Empower

The "before and after" efficacy narrative drives significant demand, shaping key industry movements

Clinical trials have demonstrated improvement in neuropathic symptoms at doses of 600 mg daily

ABCA1 gene expression remained unchanged regardless of SREBP-2 silencing

Downstream effects include concentration-dependent suppression of lipogenesis (50-70% reduction), decreased adipocyte size, and increased basal energy expenditure without appetite suppression

The fundamental difference is that GLP-1 agonists eliminate hunger and create a state of pharmaceutical appetite suppression, while AOD-9604 leaves appetite entirely unchanged

Hair growth represents another emerging application